Skip to content

AEON Biopharma, Inc.

AEON

CIK 0001837607 · Pharmaceutical Preparations · NYSE

  • Priveterra Acquisition Corp. (until 2023-07-24)
← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$13.88M
−193.4% YoY Q1 May 2026
EPS Diluted (TTM)
$1.00
−105.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$34.21M
Q1 May 2026
Cash
$6.24M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
26.31M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings